
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Ocumension Therapeutics established in May 2018, is a company which focuses on the development of ophthalmic medications. The management team of the company possesses extensive experience in R&D, clinical trials, marketing and promotion, and commercial operation. With our ocular disease focus, the company strives to continuously provide important needed therapies to Chinese patients using innovative products derived from both inhouse R&D and strategic alliance with global partners
Ocumension operates in the Pharmaceutical manufacturing industry.
Ocumension's revenue is 101m - 500m
Ocumension has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.